Get the Stockscreener App
6.91
10.49%
-0.81
Cullinan Therapeutics Inc stock is traded at $6.91, with a volume of 1.45M.
It is down -10.49% in the last 24 hours and down -12.97% over the past month.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
See More
Previous Close:
$7.72
Open:
$7.7
24h Volume:
1.45M
Relative Volume:
3.99
Market Cap:
$408.20M
Revenue:
-
Net Income/Loss:
$-153.16M
P/E Ratio:
-1.8726
EPS:
-3.69
Net Cash Flow:
$-134.48M
1W Performance:
-9.20%
1M Performance:
-12.97%
6M Performance:
-15.01%
1Y Performance:
-63.01%
1-Day Range:
$6.61
$7.70
1-Week Range:
$6.61
$7.82
52-Week Range:
$6.61
$19.66
Cullinan Therapeutics Inc Stock (CGEM) Company Profile
Name
Cullinan Therapeutics Inc
Sector
Industry
Phone
617-410-4650
Address
ONE MAIN STREET, CAMBRIDGE
Compare CGEM with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGEM
Cullinan Therapeutics Inc
|
6.91 | 442.47M | 0 | -153.16M | -134.48M | -3.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Cullinan Therapeutics Inc Stock (CGEM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-21-25 | Resumed | H.C. Wainwright | Buy |
| Jun-11-25 | Resumed | Stifel | Buy |
| Oct-24-24 | Initiated | UBS | Buy |
| May-01-24 | Initiated | Stifel | Buy |
| Apr-15-24 | Initiated | William Blair | Outperform |
| Feb-15-24 | Initiated | Wedbush | Outperform |
| Jun-15-23 | Initiated | TD Cowen | Outperform |
| Nov-21-22 | Initiated | BTIG Research | Buy |
| Apr-27-21 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Feb-02-21 | Initiated | Evercore ISI | Outperform |
| Feb-02-21 | Initiated | Morgan Stanley | Equal-Weight |
| Feb-02-21 | Initiated | SVB Leerink | Outperform |
| Feb-01-21 | Initiated | H.C. Wainwright | Buy |
View All
Cullinan Therapeutics Inc Stock (CGEM) Latest News
What the charts say about Cullinan Therapeutics Inc. todayPortfolio Risk Summary & Fast Gaining Stock Strategy Reports - Newser
Analyzing drawdowns of Cullinan Therapeutics Inc. with statistical toolsJuly 2025 Price Swings & Reliable Breakout Stock Forecasts - Newser
Chart based analysis of Cullinan Therapeutics Inc. trendsWeekly Trade Report & Risk Controlled Swing Alerts - Newser
Applying Elliott Wave Theory to Cullinan Therapeutics Inc.2025 Volume Leaders & Daily Risk Controlled Trade Plans - Newser
Can Cullinan Therapeutics Inc. ride the EV waveTrend Reversal & Capital Efficient Trade Techniques - khodrobank.com
Using data models to predict Cullinan Therapeutics Inc. stock movement2025 Technical Patterns & Intraday High Probability Alerts - Newser
Cullinan Management Updates Strategic Goals and Timeline - TipRanks
Published on: 2025-09-04 03:52:20 - Newser
Is Cullinan Therapeutics Inc. stock poised for growth2025 Market Outlook & Proven Capital Preservation Tips - Newser
Real time scanner hits for Cullinan Therapeutics Inc. explainedTrade Exit Summary & Short-Term High Return Ideas - Newser
What is Cullinan Therapeutics Inc.’s book value per shareDividend Hike & Daily Momentum Trading Reports - khodrobank.com
Is it too late to sell Cullinan Therapeutics Inc.Risk Management & Technical Pattern Alert System - Newser
Order flow analysis tools used on Cullinan Therapeutics Inc.2025 Short Interest & Daily Profit Focused Screening - Newser
Measuring Cullinan Therapeutics Inc.’s beta against major indicesJuly 2025 Macro Moves & Smart Allocation Stock Reports - Newser
Using AI based signals to follow Cullinan Therapeutics Inc.Weekly Trade Review & AI Enhanced Market Trend Forecasts - Newser
Full technical analysis of Cullinan Therapeutics Inc. stock2025 Geopolitical Influence & Smart Money Movement Tracker - Newser
Is Cullinan Therapeutics Inc. stock trending bullishWeekly Trading Summary & AI Driven Stock Movement Reports - khodrobank.com
What institutional flow reveals about Cullinan Therapeutics Inc.July 2025 Action & Weekly Setup with High ROI Potential - Newser
How to use Fibonacci retracement on Cullinan Therapeutics Inc.2025 Market Outlook & Fast Entry and Exit Trade Plans - Newser
Live market analysis of Cullinan Therapeutics Inc.Quarterly Profit Review & Free Expert Approved Momentum Trade Ideas - Newser
Is this a good reentry point in Cullinan Therapeutics Inc.Bond Market & Weekly High Potential Stock Alerts - Newser
Is Cullinan Therapeutics Inc. meeting your algorithmic filter criteria2025 Volume Leaders & Long-Term Growth Stock Strategies - Newser
Will Cullinan Therapeutics Inc. benefit from government policyMarket Movement Recap & Long-Term Safe Investment Plans - khodrobank.com
Can Cullinan Therapeutics Inc. hit a new high this monthJuly 2025 Weekly Recap & Stock Portfolio Risk Control - Newser
Real time alert setup for Cullinan Therapeutics Inc. performanceWeekly Trade Analysis & Verified Trade Idea Suggestions - Newser
Short Interest Drops in Cullinan Therapeutics Inc. After RallyProfit Target & Consistent Profit Trade Alerts - beatles.ru
Chart overlay techniques for tracking Cullinan Therapeutics Inc.Bear Alert & Technical Analysis for Trade Confirmation - Newser
Update Recap: Why is Cullinan Therapeutics Inc. stock going upJuly 2025 Breakouts & Free Real-Time Market Sentiment Alerts - khodrobank.com
Pattern recognition hints at Cullinan Therapeutics Inc. upsideWeekly Trading Summary & Expert Verified Movement Alerts - Newser
Why is Cullinan Therapeutics Inc. stock going upTrade Signal Summary & Precise Buy Zone Identification - khodrobank.com
Fibonacci Retracement Aligns with Support in Cullinan Therapeutics Inc.July 2025 Movers & AI Forecast Swing Trade Picks - beatles.ru
What Technical Tools Say About Cullinan Therapeutics Inc. Recovery getLinesFromResByArray error: size == 0 - kangso.co.kr
Is now the right time to enter Cullinan Therapeutics Inc.July 2025 Gainers & Weekly Consistent Profit Watchlists - خودرو بانک
Is Cullinan Therapeutics Inc. on track to beat earningsPortfolio Profit Report & Low Risk Entry Point Guides - خودرو بانک
Is Cullinan Therapeutics Inc. showing signs of accumulationJuly 2025 Movers & Smart Allocation Stock Reports - Newser
Analyzing net buyer seller activity in Cullinan Therapeutics Inc.July 2025 PostEarnings & Verified Short-Term Plans - Newser
Is Cullinan Therapeutics Inc. stock ready for a breakout2025 Historical Comparison & Fast Gain Stock Trading Tips - Newser
Published on: 2025-08-31 01:54:17 - Newser
Cullinan Therapeutics Inc. stock trend outlook and recovery pathJuly 2025 Trade Ideas & AI Enhanced Execution Alerts - Newser
Cullinan Therapeutics Inc Stock (CGEM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cullinan Therapeutics Inc Stock (CGEM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| AHMED NADIM | President and CEO |
Feb 25 '25 |
Sale |
8.53 |
12,529 |
106,872 |
430,621 |
| Michaelson Jennifer | Chief Scientific Officer |
Feb 25 '25 |
Sale |
8.53 |
3,756 |
32,039 |
142,004 |
| SUMER JACQUELYN L | Chief Legal Officer |
Feb 25 '25 |
Sale |
8.53 |
3,756 |
32,039 |
136,895 |
| Michaelson Jennifer | Chief Scientific Officer |
Jan 06 '25 |
Sale |
12.51 |
4,000 |
50,040 |
95,760 |
1.75%
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):